Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C2F5, C2G12, and C4E10 Monoclonal Antibody Infusions in HIV-1 Infection
NCT00219986Phase 2Completed
- Sponsor
- The Rockefeller University
- Start
- Oct 2003
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of 2F5, 2G12, 4E10 in human immunodeficiency virus infection (HIV), sponsored by The Rockefeller University. Started Oct 2003; status: completed.
02
Drugs
2F52G124E10
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00219986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219986.